Cargando…
Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells
Post-Covid pulmonary fibrosis is evident following severe COVID-19. There is an urgent need to identify the cellular and pathophysiological characteristics of chronic lung squeals of Covid-19 for the development of future preventive and/or therapeutic interventions. Tissue-resident memory T (T(RM))...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723825/ https://www.ncbi.nlm.nih.gov/pubmed/34995938 http://dx.doi.org/10.1016/j.biopha.2022.112614 |